021-51111890
购物车（）
sales@molnova.cn
Sulbactum Sodium
CAS No. 63-38-7
Sulbactum Sodium ( Cytidine-5′-diphosphate,5'-CDP )
产品货号. M22754 CAS No. 63-38-7
Sulbactum Sodium is synthesized from cytidine monophosphate (CMP) or uridine monophosphate (UMP) by the transfer of phosphoryl group, catalyzed by the enzyme uridylate kinase (UMPK).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥405 | 有现货 |
|
| 10MG | ￥608 | 有现货 |
|
| 25MG | ￥1037 | 有现货 |
|
| 50MG | ￥1555 | 有现货 |
|
| 100MG | ￥2325 | 有现货 |
|
| 200MG | ￥3491 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sulbactum Sodium
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Sulbactum Sodium is synthesized from cytidine monophosphate (CMP) or uridine monophosphate (UMP) by the transfer of phosphoryl group, catalyzed by the enzyme uridylate kinase (UMPK).
-
产品描述Sulbactum Sodium is synthesized from cytidine monophosphate (CMP) or uridine monophosphate (UMP) by the transfer of phosphoryl group, catalyzed by the enzyme uridylate kinase (UMPK)
-
同义词Cytidine-5′-diphosphate,5'-CDP
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number63-38-7
-
分子量403.18
-
分子式C9H15N3O11P2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESNc1ccn([C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)c(=O)n1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Lawrence C C , Bennati M , Obias H V . High-field EPR detection of a disulfide radical anion in the reduction of cytidine 5′-diphosphate by the E441Q R1 mutant of Escherichia coli ribonucleotide reductase[J]. Proceedings of the National Academy of ences of the United States of America, 1999, 96(16):8979-8984.
产品手册
关联产品
-
MS37452
MS37452 is a competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43 μM).
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Colesevelam Hydrochl...
Colesevelam Hydrochloride is a bile acid sequestrant with a higher affinity for glycocholic acid in vitro. Colesevelam Hydrochloride inhibits bile acid reabsorption, leading to increased bile acid synthesis and reduces cholesterol levels in patients.
